TXMD logo

TherapeuticsMD (TXMD) EV/EBITDA

EV/EBITDA

-2.99
+0.14+4.47%

20 min ago


Summary


Performance

TXMD EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherTXMDvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

TXMD EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+4.5%-4.4%-5.5%
1 m1 month+17.9%-17.8%-21.3%
3 m3 months+31.4%-31.4%-36.5%
6 m6 months+41.1%-51.4%-57.0%
ytdytd+6.3%-6.1%-7.6%
1 y1 year+29.3%-64.2%-67.8%
5 y5 years+1.6%-97.6%-99.0%

TXMD EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-monthat high-4.26+29.8%
3 m3-month-2.99at high-5.49+45.5%
6 m6-month-2.99at high-5.55+46.1%
1 y1-year-2.99at high-5.55+46.1%
3 y3-year2.53-218.2%-8.10+63.1%
5 y5-year2.53-218.2%-8.10+63.1%
alltimeall time2.99-200.0%-60.37+95.0%

TherapeuticsMD EV/EBITDA History

DateValue
2025
-2.99(-6.3%)
2024
-3.19(-17.8%)
2023
-3.88(-293.0%)
2022
2.01(-153.5%)
2021
-3.76(+8.0%)
2020
-3.48(-21.4%)
2019
-4.43(-31.7%)
2018
-6.49(-57.7%)
2017
-15.36(+37.4%)
DateValue
2016
-11.18(-46.5%)
2015
-20.91(+75.3%)
2014
-11.93(-56.3%)
2013
-27.27(+190.4%)
2012
-9.39(-5.2%)
2011
-9.90(>+9900.0%)
2010
-0.03(-99.9%)
2009
-21.94(+501.1%)
2008
-3.65(+94.1%)
2007
-1.88

FAQ

  • What is TherapeuticsMD EV/EBITDA?
  • What is the all time high EV/EBITDA for TherapeuticsMD?
  • What is TXMD EV/EBITDA year-to-date change?
  • What is TherapeuticsMD EV/EBITDA year-on-year change?

What is TherapeuticsMD EV/EBITDA?

The current EV/EBITDA of TXMD is -2.99

What is the all time high EV/EBITDA for TherapeuticsMD?

TherapeuticsMD all-time high EV/EBITDA is 2.99

What is TXMD EV/EBITDA year-to-date change?

TherapeuticsMD EV/EBITDA has changed by +0.20 (+6.27%) since the beginning of the year

What is TherapeuticsMD EV/EBITDA year-on-year change?

Over the past year, TXMD EV/EBITDA has changed by +1.24 (+29.31%)